Trachyonychia Secondary to Acitretin Usage

Trachyonychia is a disease of the nail matrix that most commonly presents with sandpaper-like roughness of the nails. Retinoids are known to cause several nail abnormalities, likely due to their anti-proliferative effects. Despite this, no cases have been previously reported on the association of ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Thieman, Taylor, Clarey, Dillon, Johnson, Richard A, Trowbridge, Ryan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029829/
https://www.ncbi.nlm.nih.gov/pubmed/32117654
http://dx.doi.org/10.7759/cureus.6703
_version_ 1783499237220155392
author Thieman, Taylor
Clarey, Dillon
Johnson, Richard A
Trowbridge, Ryan M
author_facet Thieman, Taylor
Clarey, Dillon
Johnson, Richard A
Trowbridge, Ryan M
author_sort Thieman, Taylor
collection PubMed
description Trachyonychia is a disease of the nail matrix that most commonly presents with sandpaper-like roughness of the nails. Retinoids are known to cause several nail abnormalities, likely due to their anti-proliferative effects. Despite this, no cases have been previously reported on the association of acitretin (second-generation retinoid) with trachyonychia. We present a single case of trachyonychia associated with acitretin that subsided following medication cessation.
format Online
Article
Text
id pubmed-7029829
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-70298292020-02-29 Trachyonychia Secondary to Acitretin Usage Thieman, Taylor Clarey, Dillon Johnson, Richard A Trowbridge, Ryan M Cureus Dermatology Trachyonychia is a disease of the nail matrix that most commonly presents with sandpaper-like roughness of the nails. Retinoids are known to cause several nail abnormalities, likely due to their anti-proliferative effects. Despite this, no cases have been previously reported on the association of acitretin (second-generation retinoid) with trachyonychia. We present a single case of trachyonychia associated with acitretin that subsided following medication cessation. Cureus 2020-01-19 /pmc/articles/PMC7029829/ /pubmed/32117654 http://dx.doi.org/10.7759/cureus.6703 Text en Copyright © 2020, Thieman et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Thieman, Taylor
Clarey, Dillon
Johnson, Richard A
Trowbridge, Ryan M
Trachyonychia Secondary to Acitretin Usage
title Trachyonychia Secondary to Acitretin Usage
title_full Trachyonychia Secondary to Acitretin Usage
title_fullStr Trachyonychia Secondary to Acitretin Usage
title_full_unstemmed Trachyonychia Secondary to Acitretin Usage
title_short Trachyonychia Secondary to Acitretin Usage
title_sort trachyonychia secondary to acitretin usage
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029829/
https://www.ncbi.nlm.nih.gov/pubmed/32117654
http://dx.doi.org/10.7759/cureus.6703
work_keys_str_mv AT thiemantaylor trachyonychiasecondarytoacitretinusage
AT clareydillon trachyonychiasecondarytoacitretinusage
AT johnsonricharda trachyonychiasecondarytoacitretinusage
AT trowbridgeryanm trachyonychiasecondarytoacitretinusage

Ejemplares similares